RecruitingNCT06877884

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients


Sponsor

N-Power Medicine

Enrollment

20,000 participants

Start Date

Aug 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Inclusion Criteria1

  • Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent

Exclusion Criteria1

  • Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(7)

Pacific Cancer Care

Monterey, California, United States

Bayhealth Cancer Center-Kent

Dover, Delaware, United States

Bayhealth Cancer Center- Sussex

Milford, Delaware, United States

Northwest Oncology & Hematology

Elk Grove Village, Illinois, United States

New Mexico Oncology Hematology Consultants

Albuquerque, New Mexico, United States

Lankenau Medical Center

Paoli, Pennsylvania, United States

Oncology Consultants, P.A.

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06877884


Related Trials